Table 2.
Operative procedure | N (%) |
---|---|
AVRa | 56 (81) |
AVR + CABG | 4 (6) |
AVR + MVPa | 5 (7) |
AVR + MVR | 3 (4) |
AVR + CABG + MVP | 1 (1) |
Type of valve prosthesis: | |
Mechanical | 50 (72) |
Bioprosthetic | 19 (28) |
Main location of abscess: | |
Left coronary cusp | 8 (12) |
Right coronary cusp | 5 (7) |
Non-coronary cusp | 18 (26) |
Multiple locations | 19 (28) |
– Commissure involved | 3 (4) |
– No commissure involved | 16 (23) |
Only commissural | 7 (10) |
Other | 5 (7) |
Unknown | 7 (10) |
Aortic clamp time, min | 110 ± 40 |
Cardiopulmonary bypass time, min | 157 ± 70 |
ICU stay, daysb | 2 |
Hospital stay, days | 40 |
Data are expressed as mean ± standard deviation, number (%), or median (25–75% interquartile range)
AoV aortic valve, AVR aortic valve replacement, CABG coronary artery bypass grafting, ICU intensive care unit, MV mitral valve, MVP mitral valve repair
aEither primary operation or re-operation
bIncluding 2nd ICU stay (10 patients)